google_counter
background_img

University Hospital of the Ludwig-Maximilians-University Munich (LMU)

location_on Munich, Germany
9.2/10 from 40 Votes

Department of Nuclear Medicine (344201)

Peter Bartenstein

Prof. Dr. med.

Peter Bartenstein

Specialized in: nuclear medicine

The Department of Nuclear Medicine offers for both in- and outpatients of the hospital of the Ludwig-Maximilians-University Munich the full range of modern diagnostic and therapeutic techniques of nuclear medicine including pediatric nuclear medicine and is the largest medical facility of its kind in Germany. The international recognition is approved by ISO 9001:2015 certification. Chief physician of the department is Prof. Dr. med. Peter Bartenstein.

The department specializes in a variety of diagnostic and therapeutic possibilities, in particular, in the oncology (e.g., malign tumor diseases, sentinel node diagnostics, pain therapy of bone metastases), neurology (e.g., brain diseases, Parkinson's or Alzheimer's diseases) and cardiology (e.g., cardiovascular and infarct diagnostics).

Since August 2013 the department of nuclear medicine has at its disposal a new radio-pharmaceutical center, equipped with a cyclotron, for producing radioactive pharmaceuticals of the GPM standard according to the current radiation protection and drug guidelines. This allows the department of nuclear medicine to receive all required biomarkers for diagnostics and radiopharmaceuticals for patient-tailored therapies in even less time, better quality and safety. Therefore, patient care services are provided at the highest possible level.

The range of nuclear medical diagnostics:

  • Conventional nuclear medical diagnostics (scintigraphy)
    • Hemorrhage source detection
    • Inflammation scintigraphy
    • Brain scintigraphy
    • Testicular scintigraphy
    • Bone marrow scintigraphy
    • Hepatic scintigraphy
    • Etc.
  • Positron emissions tomography (PET)
    • PET/CT within the oncological diagnostics
    • PET in neurological / neuro-oncological diagnostics
    • PET and PET/CT in other diagnostic issues (e.g., cardiology, etc.)

Radio-pharmaceuticals are successfully utilized for therapeutic purposes. Apart from benign and malignant thyroid diseases, the physicians of the department also apply pain therapy for skeletal metastases, joint therapy (radiosynoviorthesis, e.g., for rheumatic diseases), therapy of neuroendocrine tumors and especially the SIRT-therapy of liver metastases. These nuclear medical therapy options are often elaborated in a close cooperation with other disciplines (e.g., oncologists, endocrinologists, gynecologists, surgeons, orthopedists), for instance, within the Comprehensive Cancer Center (CCC) or the Breast Center.

The range of the therapeutic nuclear medicine:

  • Therapy of benign thyroid diseases
  • Therapy of malignant thyroid diseases
  • Therapy of malignant prostate diseases
  • Therapy of neuroendocrine tumors
  • Therapy of Metaiodobenzylguanidine (MIBG)
  • SIRT - selective internal radiation therapy
  • Therapy of skeletal metastases
  • Radiosynoviorthesis (RSO)
  • Etc.

Need Help?

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.